Enlaza Therapeutics
Covalent Protein Biologics | Home
Enlaza Therapeutics was founded in 2021, is headquartered in San Diego, United States, lists 51–200 employees, and has $161.0M in recorded funding across 2 rounds.
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2021
- Business Model
- B2B
- Website
- enlazatx.com
- Total Funding
- $161.0M
- Last Round
- $100.0M Series AApr 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 10 investors for this company. The full record is or through the API.
About
Enlaza Therapeutics is a preclinical-stage biotech developing first-in-class covalent protein therapeutics, or 'War-Lock' biologics, to treat cancer and other serious diseases. Its proprietary platform incorporates unnatural amino acids into protein drugs to create irreversible, target-specific covalent bonds, aiming to improve efficacy and reduce off-target toxicity compared to standard biologics. The company is backed by investors including J.P. Morgan Life Sciences Private Capital, Frazier Life Sciences, Avalon Ventures, Lightspeed Venture Partners, and Samsara BioCapital, and announced a strategic collaboration with Vertex Pharmaceuticals in September 2025.
Summary
Enlaza Therapeutics is a Biotech company based in San Diego, United States, founded in 2021. It lists 51–200 employees. It has raised $161.0M in total across 2 rounds, most recently a $100.0M Series A round in Apr 2024. Investors include J.P. Morgan Asset Management, Avalon Ventures and Amgen.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/enlaza-therapeutics"><img src="https://indexed.vc/api/badge/company/enlaza-therapeutics" alt="Enlaza Therapeutics on Indexed.vc" width="260" height="76" /></a>


